keratan-sulfate and Precancerous-Conditions

keratan-sulfate has been researched along with Precancerous-Conditions* in 3 studies

Other Studies

3 other study(ies) available for keratan-sulfate and Precancerous-Conditions

ArticleYear
Lumican as a novel marker for differential diagnosis of Bowen disease and actinic keratosis.
    The American Journal of dermatopathology, 2013, Volume: 35, Issue:8

    Lumican, a member of the small leucine-rich proteoglycan family, regulates the assembly and diameter of collagen fibers in the extracellular matrix of various tissues. Lumican expression correlates with pathological conditions, including skin fragility, corneal opacification, and corneal and cardiac wound healing. Lumican is overexpressed in tumor cells, including in the breast, colorectal, neuroendocrine cell, uterine cervical, and pancreatic cancers. Lumican expression also correlates with the growth and metastasis of various malignancies. For example, lumican expression is lower in the dermis of malignant melanoma cases than in early-stage melanomas. However, the expression patterns and roles of lumican in nonmelanoma skin cancer have not been elucidated. In this study, we used immunohistochemistry and in situ hybridization to examine the expression patterns of lumican in normal skin, Bowen disease, and actinic keratosis. In normal skin, lumican was expressed in the collagen fibers in the dermis, acrosyringium, follicular epithelium, and sebocytes but not in epidermal keratinocytes. In Bowen disease, lumican was expressed in 34 (91.8%) of 37 patients. Notably, all cases of actinic keratosis were negative for lumican. These findings suggest that lumican plays an important role in the pathogenesis of Bowen disease and actinic keratosis and might be useful as an adjunct to the diagnosis for subtypes of 2 diseases: bowenoid actinic keratosis and Bowen disease in sun-exposed areas.

    Topics: Aged; Aged, 80 and over; Biomarkers; Bowen's Disease; Chondroitin Sulfate Proteoglycans; Diagnosis, Differential; Female; Humans; Immunohistochemistry; In Situ Hybridization; Keratan Sulfate; Keratosis, Actinic; Lumican; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms

2013
Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia.
    American journal of clinical pathology, 2011, Volume: 135, Issue:2

    Lobular endocervical glandular hyperplasia (LEGH) is a distinct benign glandular lesion expressing gastric gland mucous cell-type mucin (N-acetylglucosaminα1 → 4galactose → R [GlcNAcα1 → 4Gal → R]). To investigate histogenesis and diagnostic markers of LEGH, we examined the immunohistochemical expression profile of gastric surface mucous cell (MUC5AC and TFF1), gastric gland mucous cell (MUC6, TFF2, and GlcNAcα1 → 4Gal → R), gastric pyloric epithelial cell (PDX1), and endocervical cell (keratan sulfate) markers in normal endocervix samples and benign glandular lesions (nabothian cysts, tunnel clusters, and LEGHs). MUC5AC and MUC6 were expressed in normal endocervical mucosa and benign glandular lesions. TFF1, TFF2, GlcNAcα1 → 4Gal → R, and PDX1 were expressed only in LEGH. Keratan sulfate was expressed in normal endocervical mucosa and benign glandular lesions. In LEGH, gastric surface mucous cell and gastric gland mucous cell differentiation were demonstrated, and transdifferentiation from endocervical mucosa into gastric pyloric mucosa was suggested. In addition to GlcNAcα1 → 4Gal → R, TFF1, TFF2, and PDX1 are additional useful markers for LEGH.

    Topics: Adult; Aged; Cervix Uteri; Female; Homeodomain Proteins; Humans; Hyperplasia; Keratan Sulfate; Middle Aged; Mucin 5AC; Mucin-6; Mucous Membrane; Peptides; Precancerous Conditions; Pylorus; Trans-Activators; Trefoil Factor-1; Trefoil Factor-2; Tumor Suppressor Proteins; Uterine Cervical Neoplasms

2011
Mammographic density is related to stroma and stromal proteoglycan expression.
    Breast cancer research : BCR, 2003, Volume: 5, Issue:5

    Mammographic density and certain histological changes in breast tissues are both risk factors for breast cancer. However, the relationship between these factors remains uncertain. Previous studies have focused on the histology of the epithelial changes, even though breast stroma is the major tissue compartment by volume. We have previously identified lumican and decorin as abundant small leucine-rich proteoglycans in breast stroma that show altered expression after breast tumorigenesis. In this study we have examined breast biopsies for a relationship between mammographic density and stromal alterations.. We reviewed mammograms from women aged 50-69 years who had enrolled in a provincial mammography screening program and had undergone an excision biopsy for an abnormality that was subsequently diagnosed as benign or pre-invasive breast disease. The overall mammographic density was classified into density categories. All biopsy tissue sections were reviewed and tissue blocks from excision margins distant from the diagnostic lesion were selected. Histological composition was assessed in sections stained with haematoxylin and eosin, and the expression of lumican and decorin was assessed by immunohistochemistry; both were quantified by semi-quantitative scoring.. Tissue sections corresponding to regions of high in comparison with low mammographic density showed no significant difference in the density of ductal and lobular units but showed significantly higher collagen density and extent of fibrosis. Similarly, the expression of lumican and decorin was significantly increased.. Alteration in stromal composition is correlated with increased mammographic density. Although epithelial changes define the eventual pathway for breast cancer development, mammographic density might correspond more directly to alterations in stromal composition.

    Topics: Aged; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chondroitin Sulfate Proteoglycans; Cohort Studies; Decorin; Extracellular Matrix Proteins; Female; Humans; Hyperplasia; Immunohistochemistry; Keratan Sulfate; Lumican; Mammography; Middle Aged; Precancerous Conditions; Proteoglycans; Risk Factors; Stromal Cells

2003